|
|
|
|
| Join the 5th iPSC Drug Development Summit, October 1-2, in Boston - your go-to event for uniting iPSC drug developers across R&D to CMC. Hear from 30+ expert leaders from Aspen Neuroscience, Novo Nordisk, BlueRock Therapeutics and more, as they share their expertise across two tracks: Preclinical or Process Development & CMC. If you are a drug developer or an academic, you can claim a complimentary pass. Register here |
|
|
|
|
By Vadim Klyushnichenko, Outsourced Pharma Board Member | This continues our discussion of AI and CDMOs, focusing on biologics and cell and gene therapy (CGT) relationships. Outsourced Pharma Board Member Vadim | |
|
|
|
| IND-Enabling Programs For Adoptive Cell Therapies | Article | Labcorp Cell and Gene Therapy Solutions | Accelerating the development of adoptive cell therapies through robust preclinical strategies and regulatory pathways is crucial to bringing these life-saving treatments to patients in need. |
|
|
|
|
|
|
|
|
| Effectively Enabling Rare Diseases To Reach Patients | Article | By Dr. Rebecca Abram and Dr. Joanna Norman, FUJIFILM Biotechnologies | To manufacture your rare disease therapy cost effectively, partner with an experienced CDMO from the outset. The right partner will offer development, manufacturing, quality, and regulatory expertise. |
|
|
| Securing INmune Bio's Trial Materials In A Crisis | Article | Cryoport Systems | Discover how a sudden biostorage shutdown put INmune Bio’s trial at risk, revealing the critical importance of logistics and rapid coordination in protecting advanced therapy programs. |
|
|
|
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
Connect With Cell & Gene: |
|
|
|